Research Nester published a report titled “Digital Pathology Market: Global Demand Analysis & Opportunity Outlook 2033” which delivers detailed overview of the global digital pathology market in terms of market segmentation by component type, application, end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
Read more information’s@ https://www.researchnester.com/reports/digital-pathology-market/176
The global digital pathology market is anticipated to grow with a CAGR of ~11% during the forecast period, i.e., 2023-2033. The market is segmented by end-user into hospitals, clinics, diagnostic & private laboratories and research centers. Out of these, the hospitals segment is anticipated to garner the largest revenue by the end of 2033. The rapid adoption of digital scanning techniques for early and quick diagnosis of patient diseases coupled with rising support by the government in the development of hospitals are expected to augment segment growth over the forecast period.
The global digital pathology market is estimated to garner a revenue of ~USD 2450 Million by the end of 2033. Further, the market generated a revenue of ~USD 1029 Million in the year 2022. Growing adoption of digital imaging, rise in chronic and blood-borne diseases, increasing laboratory tests along with acceptance of AI in healthcare are some of the major factors anticipated to drive the growth of the market during the forecast period.
Geographically, the global digital pathology market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in North America is projected to garner the largest revenue by the end of 2033 owing to the rise in the number of elderly people coupled with the increasing incidence of chronic diseases. In addition, the rising government initiatives and R&D investments, coupled with the growth of IT healthcare in the region are anticipated to drive the market in North America over the forecast period.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Surge in Incidence of Cardiovascular Diseases (CVDs) to Drive the Market Growth
According to the World Health Organization, a projected 17.9 million deaths occurred caused by cardiovascular diseases in 2019, representing for 32% of overall deaths.
Chronic conditions are becoming more prevalent, and digital pathology is expected to become more essential to treating patients, improving diagnostic performance, and reducing the high costs of conventional diagnostics. Mortality rates for chronic diseases are high. There is a high prevalence of cardiovascular diseases (CVDs), which necessitates advanced diagnostic procedures and imaging studies.
However, high maintenance and installation charges of software are expected to operate as key restraint to the growth of global digital pathology market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global digital pathology market which includes company profiling of ContextVision AB, Leica Biosystems Nussloch GmbH, GE Healthcare, Ventana Medical Systems Inc., Hamamatsu Photonics K.K., Apollo Enterprise Imaging Corporation, Xifin Inc., Definiens AG., Inspirata, Inc., 3DHISTECH Ltd. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global digital pathology market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.researchnester.com/sample-request-176
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919